1-PALMITOYL(D31)-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-L-SERINE](SODIUM SALT)
Modify Date: 2024-02-05 21:00:03
 Structure](https://image.chemsrc.com/caspic/112/327178-96-1.png)
1-PALMITOYL(D31)-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-L-SERINE](SODIUM SALT) structure
|
Common Name | 1-PALMITOYL(D31)-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-L-SERINE](SODIUM SALT) | ||
|---|---|---|---|---|
| CAS Number | 327178-96-1 | Molecular Weight | 815.179 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C40H44D31NNaO10P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-PALMITOYL(D31)-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-L-SERINE](SODIUM SALT)16:0-18:1 PS-d31 (sodium) is deuterium labeled 16:0-18:1 PS (sodium). |
| Name | Sodium (2S,8R,18Z)-2-ammonio-8-{[(2H31)hexadecanoyloxy]methyl}-5-oxido-10-oxo-4,6,9-trioxa-5-phosphaheptacos-18-en-1-oate 5-oxide |
|---|---|
| Synonym | More Synonyms |
| Description | 16:0-18:1 PS-d31 (sodium) is deuterium labeled 16:0-18:1 PS (sodium). |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2]. |
| References |
| Molecular Formula | C40H44D31NNaO10P |
|---|---|
| Molecular Weight | 815.179 |
| Exact Mass | 814.697205 |
| 9-Octadecenoic acid, (1R)-2-[[[(2S)-2-amino-2-carboxyethoxy]hydroxyphosphinyl]oxy]-1-[[(1-oxohexadecyl-2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-d)oxy]methyl]eth yl ester, sodium salt, (9Z)- (1:1) |
| Sodium (2S,8R,18Z)-2-ammonio-8-{[(H)hexadecanoyloxy]methyl}-5-oxido-10-oxo-4,6,9-trioxa-5-phosphaheptacos-18-en-1-oate 5-oxide |